Business Standard

Lupin launches cholesterol drug Atorvastatin Calcium Tablets

Image

Capital Market
Lupin announced the launch of Atorvastatin Calcium Tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, having received an approval from the United States Food and Drug Administration (USFDA) earlier. The product will be manufactured at Lupin's Nagpur facility in India.

Atorvastatin Calcium Tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, is the generic equivalent of Lipitor Tablets, 10 mg, 20 mg, 40 mg and 80 mg, of Pfizer Inc., and indicated to lower cholesterol in blood for adults and children over 10 years of age. Atorvastatin is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases, diabetes and other risk factors such as eye problems, kidney diseases or high blood pressure.

 

Atorvastatin Calcium Tablets USP (RLD: Lipitor) had annual sales of approximately USD 559 million in the U.S. (IQVIA MAT July 2020).

Click here to connect with us on WhatsApp

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 28 2020 | 1:40 PM IST

Explore News